Lexitas Pharma Services

Team Lexitas is excited to head to Orlando, Oct 16-20, for Eyecelerator & the American Academy of Ophthalmology Annual Meeting! Members of our Leadership, BD, and Clin Ops teams will join thousands of other ophthalmic experts for a weekend of networking, innovation, and insights. If you're planning to attend either event, you can click below to schedule a time to connect! ⬇️ https://hubs.li/Q03J8y1L0 #AAO2025 #Eyecelerator #ophthalmology

Can you believe AAO 2025 kicks off in just 2 weeks?! Our CMO, David J. Tanzer, MD, will participate in the subspecialty days beginning Oct 17, before the expo kicks off on Oct 18-20. Stop by Booth #3470 to say hi to the team and pick up some Lexitas merch! Click to schedule a meeting with our team in Orlando ➡️ https://hubs.li/Q03M7S910 American Academy of Ophthalmology Eyecelerator #AAO2025 Jeanne Hecht Catherine Bryson Babineaux Yesha Raval Sarah Hines Brett Rush Dre Long Donna Sedoti

"For now, maze-based mobility assessments remain at the center of IRD drug development, but the future promises more precise tools, scalable and patient-centric measures paving the way for transformative treatments for patients in need." In a recent article with Modern Retina, our CMO, David J. Tanzer, MD, joins Daniel C. Chung, DO, MA from Beacon Therapeutics, as well as Huma Q. and Murthy Chavali, Ph.D. from Ocugen, to discuss functional endpoints for Inherited Retinal Disease trials. They delve into breakthrough cases, the unique challenges of IRD drug development, real-world vs. virtual assessments, and key regulatory considerations. Read the full article today➡️➡️ https://hubs.li/Q03LMTJR0 #IRD #retina #clinicalinsights

There's still time to register for our upcoming live webinar! Jeanne Hecht and David J. Tanzer, MD will discuss everything from the state of the ophthalmology investment space to emerging endpoints and biomarker evolution in ophthalmic clinical trials. Click below for more information ⬇️⬇️

"I chose Lexitas over other CROs because of its culture and great reputation. The company values its employees and sponsors." We asked Senior CRA, Rocio Zamora, about her background in the industry and what led her to join Lexitas. Her depth of experience in ophthalmology and clinical research is a tremendous asset to our sponsors and partners. Thank you for everything you do, Rocio! #employeespotlights #lexitas #cro

Lexitas is honored to sponsor the Mary Tyler Moore Vision Initiative's Fall 2025 Symposium! Our CEO, Jeanne Hecht, and CMO, David J. Tanzer, MD, will be in Ann Arbor on November 2–3 for this two-day event. The symposium will focus on “Curing Vision Loss from Diabetes" and will bring together patients, clinicians, and various industry leaders. Let us know if you'll be attending! Visit their website to learn more about this event and the MTMVI's mission and impact: https://hubs.li/Q03LbXkR0 #DRD #ophthalmology #diabetes #MaryTylerMoore

We’re proud of the partnerships we’ve built—and even prouder of the feedback we’ve received. We are so grateful to our many advocates for their confidence and support. It's an honor to work with so many leaders and innovators in the ophthalmology space. Sean McDonald (Ocugenix) Sonja Krösser (Novaliq GmbH) David Esposito (ONL Therapeutics Justin Hanes (Novus Vision) Ben Yerxa (Opus Genetics) #Ophthalmology #Lexitas

In a recent article with Clinical Research News, our Operational Strategy Director, Yesha Raval, and Chris Bartizal from MIDWEST CORNEA ASSOCIATES, LLC discuss the importance of keeping patients engaged throughout the course of a trial. Yesha and Chris delve into: ▪️Site-Study Alignment ▪️Statistical Validity ▪️Cost & Timelines ▪️Human Impact ▪️Retention Strategies Check out the full article today: https://hubs.li/Q03KCSVJ0 #clinicalresearch #clinicaltrials #clinicalinsights

Thank you, Sharron, for featuring our incredible CEO on the #SheLeadsBiotech podcast! If you're in need of some Friday morning listening material, click below ⬇️